Therapeutic advantages of long-acting trimetazidine for the treatment of stable angina pectoris in routine clinical practice: findings from ODA trial
28 August 2018 (14:00 - 18:00)
Organised by:
Abstract
About the speaker
I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)
16 More presentations in this session
Access the full session
The Event
ESC Congress 2018
28 August 2018
14:00 CET
